Type-specific persistence of high-risk human papillomavirus infections in the new independent states of the former soviet union cohort study

被引:42
作者
Kulmala, Satu-Maria A.
Shabalova, Irena P.
Petrovitchev, Nikolay
Syrjanen, Kari J.
Gyllensten, Ulf B.
Johansson, Bo C.
Syrjanen, Stina M.
机构
[1] Univ Turku, Dept Oral Pathol, Inst Dent, FIN-20520 Turku, Finland
[2] Univ Turku, Fac Med, Medicity Res Lab, FIN-20520 Turku, Finland
[3] Russian Acad Med Sci, NN Blokhin Canc Res Ctr, Moscow, Russia
[4] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland
[5] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden
[6] Karolinska Univ Hosp, Div Clin Virol, Dept Lab Med, Huddinge, Sweden
[7] Karolinska Inst, Stockholm, Sweden
关键词
D O I
10.1158/1055-9965.EPI-06-0649
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Prospective follow-up studies have recently suggested that persistent high-risk human papillomavirus (HPV) infections play a key role in the progression of CIN lesions and in the development of cervical cancer. However, data on type-specific persistence, viral integration, and the role of multiple infections are scanty. Materials and Methods: A cross-sectional/cohort study was conducted between 1998 and 2002 in three New Independent States of the former Soviet Union comprising a cohort of 3,187 women, of whom 854 women were followed up for a mean of 17 months (SD, 11.6). HPV genotyping was done with real-time PCR, detecting HPV types 16, 18/45, 31, 33/52/ 58, 35, and 39. The integration status of HPV16 was examined by using a novel Taqman-based PCR method. Results: The mean clearance time for the individual high-risk-type infection was 16.5 months (range = 0.9-34.9 months). HPV16 and HPV31 were the most persistent infections (clearance times = 18.1 and 16.2 months, respectively), whereas HPV39 infections cleared most rapidly. The mean copies per cell in HPV18/45, HPV31, HPV33/52/58, and HPV39 infections were higher in persisting HPV infections than in HPV infections that cleared, but the difference was not significant. Integration of HPV16 was not found to correlate with HPV persistence. Conclusions: A large proportion of women remained high-risk HPV positive after 18 months. Coinfection with multiple HPV types, viral load, or integration status did not correlate with persistence of high-risk HPV infections.
引用
收藏
页码:17 / 22
页数:6
相关论文
共 30 条
[1]   Persistence and load of high-risk hpv are predictors for development of high-grade cervical lesions:: A longitudinal French cohort study [J].
Dalstein, W ;
Riethmuller, D ;
Prétet, JL ;
Carval, KL ;
Sautière, JL ;
Carbillet, JP ;
Kantelip, B ;
Schaal, JP ;
Mougin, C .
INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (03) :396-403
[2]   Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer [J].
Franco, EL ;
Villa, LL ;
Sobrinho, JP ;
Prado, JM ;
Rousseau, MC ;
Désy, M ;
Rohan, TE .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (05) :1415-1423
[3]   Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The young women's health study [J].
Giuliano, AR ;
Harris, R ;
Sedjo, RL ;
Baldwin, S ;
Roe, D ;
Papenfuss, MR ;
Abrahamsen, M ;
Inserra, P ;
Olvera, S ;
Hatch, K .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (04) :462-469
[4]   Natural history of cervicovaginal papillomavirus infection in young women [J].
Ho, GYF ;
Bierman, R ;
Beardsley, L ;
Chang, CJ ;
Burk, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (07) :423-428
[5]   Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis [J].
Kalantari, M ;
Karlsen, F ;
Kristensen, G ;
Holm, R ;
Hagmar, B ;
Johansson, B .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1998, 17 (02) :146-153
[7]   Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools [J].
Kulmala, SM ;
Syrjänen, S ;
Shabalova, I ;
Petrovichev, N ;
Kozachenko, V ;
Podistov, J ;
Ivanchenko, O ;
Zakharenko, S ;
Nerovjna, R ;
Kljukina, L ;
Branovskaja, M ;
Grunberga, V ;
Juschenko, A ;
Tosi, P ;
Santopietro, R ;
Syrjänen, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (06) :2470-2475
[8]   Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology [J].
Kulmala, SMA ;
Syrjänen, SM ;
Gyllensten, UB ;
Shabalova, IP ;
Petrovichev, N ;
Tosi, P ;
Syrjänen, KJ ;
Johansson, BC .
JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (05) :513-517
[9]   Variants of the long control region of human papillomavirus type 16 [J].
Kurvinen, K ;
Yliskoski, M ;
Saarikoski, S ;
Syrjänen, K ;
Syrjänen, S .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (11) :1402-1410
[10]   A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types [J].
Liaw, KL ;
Hildesheim, A ;
Burk, RD ;
Gravitt, P ;
Wacholder, S ;
Manos, MM ;
Scott, DR ;
Sherman, ME ;
Kurman, RJ ;
Glass, AG ;
Anderson, SM ;
Schiffman, M .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (01) :8-15